Nexplanon 68 MG implants
Ended Awarded Last action
- Contract number
- SPE2DR26FFBX5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,763
Award facts
- Contract value 100% obligated
- $16,762.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $16,762.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nexplanon 68 mg implants. The delivery order, issued on January 15, 2026, with an ultimate completion date of February 6, 2026, carries no set-aside designation, indicating the contractor competed in unrestricted federal procurement. This award is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion contract awarded in November 2025 with a completion date of December 31, 2036.
The PPV-G GEN V initiative represents part of the broader $30.3 billion Defense Logistics Agency pharmaceutical acquisition strategy designed to support recurring medical supply needs of military healthcare facilities worldwide. DMS Pharmaceutical Group, registered in the System for Award Management since 2001, has demonstrated substantial federal contracting activity as a critical supplier within the Department of Defense pharmaceutical supply chain, with delivery orders spanning diverse therapeutic categories including specialty pharmaceuticals, biologics, vaccines, and medical consumables. This delivery order for contraceptive implants reflects the company's established capability to fulfill specialized pharmaceutical requirements across the military medical system without identified subcontractor relationships.
Quick answers
Who was awarded contract SPE2DR26FFBX5?
SPE2DR26FFBX5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FFBX5 worth?
The government has obligated $16,763 on SPE2DR26FFBX5.
Is contract SPE2DR26FFBX5 an order under another contract?
Yes. SPE2DR26FFBX5 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBX5 competed?
The extent of competition for SPE2DR26FFBX5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award